BioCentury | Aug 3, 2018
Finance

Lin’s new chapters

...Taiwanese biotech Lin Bioscience Inc. and its wholly owned San Diego subsidiary Lin Bioscience Co. Ltd. are planning sequential...
...market and finance that company in the U.S.,” said Financial Director Hao-Yuan Chuang. Hongjiang Li, Staff Writer LBS-002 LBS-007 LBS-008 Lin BioScience Inc. Cell...
BioCentury | Mar 24, 2017
Company News

Columbia University, Memorial Sloan Kettering, Lin BioScience deal

...The university and Memorial Sloan granted Lin BioScience exclusive, worldwide rights to LBS-007 and related IP. Lin...
...Sloan Kettering Cancer Center , New York, N.Y. Lin BioScience Inc. , Taipei, Taiwan Business: Cancer Alex Himes Columbia University Lin BioScience Inc. Memorial...
BioCentury | Jan 20, 2017
Company News

Columbia University, Lin Bioscience deal

...The university granted Lin Bioscience exclusive, worldwide rights to preclinical candidate LBS-008 and related IP. Lin expects...
...Phase I testing this year to treat dry age-related macular degeneration (AMD) and Stargardt's disease. Lin Bioscience...
...New York, N.Y. Lin Bioscience, San Diego, Calif. Business: Ophthalmic Shannon Lehnbeuter Columbia University Retinol binding protein 4 plasma (RBP4) Lin Bioscience...
Items per page:
1 - 3 of 3
BioCentury | Aug 3, 2018
Finance

Lin’s new chapters

...Taiwanese biotech Lin Bioscience Inc. and its wholly owned San Diego subsidiary Lin Bioscience Co. Ltd. are planning sequential...
...market and finance that company in the U.S.,” said Financial Director Hao-Yuan Chuang. Hongjiang Li, Staff Writer LBS-002 LBS-007 LBS-008 Lin BioScience Inc. Cell...
BioCentury | Mar 24, 2017
Company News

Columbia University, Memorial Sloan Kettering, Lin BioScience deal

...The university and Memorial Sloan granted Lin BioScience exclusive, worldwide rights to LBS-007 and related IP. Lin...
...Sloan Kettering Cancer Center , New York, N.Y. Lin BioScience Inc. , Taipei, Taiwan Business: Cancer Alex Himes Columbia University Lin BioScience Inc. Memorial...
BioCentury | Jan 20, 2017
Company News

Columbia University, Lin Bioscience deal

...The university granted Lin Bioscience exclusive, worldwide rights to preclinical candidate LBS-008 and related IP. Lin expects...
...Phase I testing this year to treat dry age-related macular degeneration (AMD) and Stargardt's disease. Lin Bioscience...
...New York, N.Y. Lin Bioscience, San Diego, Calif. Business: Ophthalmic Shannon Lehnbeuter Columbia University Retinol binding protein 4 plasma (RBP4) Lin Bioscience...
Items per page:
1 - 3 of 3